Filing Details

Accession Number:
0001209191-18-013961
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-02-27 16:50:48
Reporting Period:
2018-02-23
Accepted Time:
2018-02-27 16:50:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
920465 La Jolla Pharmaceutical Co LJPC Biological Products, (No Disgnostic Substances) (2836) 330361285
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1178579 C Kevin Tang 4747 Executive Drive, Suite 510
San Diego CA 92121
Yes No Yes No
1191935 Tang Capital Partners Lp 4747 Executive Drive, Suite 510
San Diego CA 92121
No No Yes No
1232621 Tang Capital Management Llc 4747 Executive Drive, Suite 510
San Diego CA 92121
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-02-23 10,000 $31.54 3,450,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-23 10,000 $31.94 3,460,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-23 10,000 $32.42 3,470,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-23 20,000 $32.58 3,490,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-23 10,000 $32.30 3,500,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-26 10,000 $32.92 3,510,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-26 10,000 $32.48 3,520,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-26 1,000 $32.50 3,521,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-27 9,000 $32.70 3,530,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-27 10,000 $32.17 3,540,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-27 10,000 $30.57 3,550,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-27 10,000 $30.88 3,560,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-27 10,000 $30.87 3,570,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-27 10,000 $30.69 3,580,419 No 4 P Indirect By LP
Common Stock Acquisiton 2018-02-27 10,000 $30.60 3,590,419 No 4 P Indirect By LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
No 4 P Indirect By LP
Footnotes
  1. The securities are beneficially owned by Tang Capital Partners, LP ("TCP"). Kevin C. Tang is the sole manager of Tang Capital Management, LLC, which is the general partner of TCP.